{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:10:47Z","timestamp":1791835847418,"version":"4.3.4"},"reference-count":108,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["ID1158013"],"award-info":[{"award-number":["ID1158013"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.tips.2022.04.005","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T06:03:34Z","timestamp":1656569014000},"page":"940-956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Current landscape of preclinical models of diabetic cardiomyopathy"],"prefix":"10.1016","volume":"43","author":[{"given":"Darnel","family":"Prakoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4797-5193","authenticated-orcid":false,"given":"Miles J.","family":"De Blasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchel","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8610-0058","authenticated-orcid":false,"given":"Rebecca H.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2022.04.005_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.tips.2022.04.005_bb0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2022.04.005_bb0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"71","author":"Marwick","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0020","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2022.04.005_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2022.04.005_bb0030","first-page":"e563","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary. Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0035","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diacare.29.03.06.dc05-1501","article-title":"Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"29","author":"Bertoni","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tips.2022.04.005_bb0040","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","article-title":"Impact of diabetes on cardiac structure and function: the strong heart study","volume":"101","author":"Devereux","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2022.04.005_bb0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jcp.46.1.32","article-title":"Collagen remodelling in myocardia of patients with diabetes","volume":"46","author":"Shimizu","year":"1993","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.tips.2022.04.005_bb0050","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/01.CIR.82.3.848","article-title":"A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease","volume":"82","author":"van Hoeven","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2022.04.005_bb0055","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","article-title":"Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: The Framingham Heart Study","volume":"107","author":"Vasan","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2022.04.005_bb0060","doi-asserted-by":"crossref","first-page":"FSO63","DOI":"10.4155\/fso.15.63","article-title":"Animal models are essential to biological research: issues and perspectives","volume":"1","author":"Barr\u00e9-Sinoussi","year":"2015","journal-title":"Future Sci."},{"key":"10.1016\/j.tips.2022.04.005_bb0065","first-page":"5","article-title":"Animal models in translational medicine: validation and prediction","volume":"2","author":"Denayer","year":"2014","journal-title":"New Horiz. Transl. Med."},{"key":"10.1016\/j.tips.2022.04.005_bb0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/cvr\/cvab043","article-title":"Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart","volume":"118","author":"Prakoso","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2022.04.005_bb0075","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/db09-1456","article-title":"Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy","volume":"59","author":"Huynh","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2022.04.005_bb0080","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1007\/s00125-012-2720-0","article-title":"Enhanced phosphoinositide 3-kinase(p110\u03b1) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes","volume":"55","author":"Ritchie","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2022.04.005_bb0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fphys.2020.00124","article-title":"Defining the progression of diabetic cardiomyopathy in a mouse model of type 1 diabetes","volume":"11","author":"De Blasio","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0090","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00125-012-2495-3","article-title":"Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db\/db mouse model of type 2 diabetes","volume":"55","author":"Huynh","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2022.04.005_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165807","article-title":"Empagliflozin improves left ventricular diastolic function of db\/db mice","volume":"1866","author":"Moellmann","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.tips.2022.04.005_bb0100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tips.2022.04.005_bb0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/cvr\/cvn093","article-title":"Insulin signalling in the heart","volume":"79","author":"Bertrand","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2022.04.005_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/461967","article-title":"Alteration of energy substrates and ROS production in diabetic cardiomyopathy","volume":"2013","author":"Lorenzo","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.tips.2022.04.005_bb0115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ncpcardio1347","article-title":"Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy","volume":"5","author":"Lebeche","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.tips.2022.04.005_bb0120","doi-asserted-by":"crossref","first-page":"H567","DOI":"10.1152\/ajpheart.00650.2012","article-title":"Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-\u03baB","volume":"304","author":"Wang","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0125","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1042\/CS20170064","article-title":"Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1\/2 pathway","volume":"131","author":"Xu","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.tips.2022.04.005_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcvm.2019.00045","article-title":"Transgenic expression of miR-133a in the diabetic Akita heart prevents cardiac remodeling and cardiomyopathy","volume":"6","author":"Kambis","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.tips.2022.04.005_bb0135","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3389\/fphys.2018.01275","article-title":"MiR-133a mimic alleviates T1DM-induced systolic dysfunction in Akita: an MRI-based study","volume":"9","author":"Nandi","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0140","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2337\/db09-0259","article-title":"Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic Akita mice","volume":"58","author":"Bugger","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2022.04.005_bb0145","series-title":"Animal Models of Diabetes","first-page":"87","article-title":"Mouse models of autoimmune diabetes: the nonobese diabetic (NOD) mouse","author":"Chen","year":"2020"},{"key":"10.1016\/j.tips.2022.04.005_bb0150","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2337\/db11-1293","article-title":"Islet \u03b2-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model","volume":"61","author":"Tersey","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2022.04.005_bb0155","series-title":"Animal Models of Diabetes","first-page":"69","article-title":"Rat models of human type 1 diabetes","author":"Lenzen","year":"2020"},{"key":"10.1016\/j.tips.2022.04.005_bb0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0008-6363(00)00011-0","article-title":"Attenuated cardiac contractile responsiveness to insulin-like growth factor I in ventricular myocytes from biobreeding spontaneous diabetic rats","volume":"46","author":"Ren","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2022.04.005_bb0165","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1152\/japplphysiol.01626.2011","article-title":"Exercise-induced cardiac performance in autoimmune (Type 1) diabetes is associated with a decrease in myocardial diacylglycerol","volume":"113","author":"Loganathan","year":"2012","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0170","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db16-0733","article-title":"The sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents cardiomyopathy in a diabetic lipodystrophic mouse model","volume":"66","author":"Joubert","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2022.04.005_bb0175","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129781","article-title":"Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy","volume":"4","author":"Zhou","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.tips.2022.04.005_bb0180","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00125-013-2926-9","article-title":"Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2\/seipin-deficient mice","volume":"56","author":"Prieur","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2022.04.005_bb0185","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1038\/ncomms13496","article-title":"Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic \u03b2-cells","volume":"7","author":"Brereton","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2022.04.005_bb0190","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","article-title":"The mechanisms of alloxan- and streptozotocin-induced diabetes","volume":"51","author":"Lenzen","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2022.04.005_bb0195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nucmedbio.2016.04.002","article-title":"Cardiovascular side-effects and insulin secretion after intravenous administration of radiolabeled Exendin-4 in pigs","volume":"43","author":"Ryd\u00e9n","year":"2016","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.tips.2022.04.005_bb0200","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/785948","article-title":"Nonhuman primate models of type 1 diabetes mellitus for islet transplantation","volume":"2014","author":"Zhu","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.tips.2022.04.005_bb0205","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jcjd.2017.10.032","article-title":"Antioxidant role of vitamin D in mice with alloxan-induced diabetes","volume":"42","author":"Iqbal","year":"2018","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.tips.2022.04.005_bb0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.etp.2004.09.002","article-title":"Gene expression profiling in streptozotocin treated mouse liver using DNA microarray","volume":"56","author":"Kume","year":"2005","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.tips.2022.04.005_bb0215","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.tips.2022.04.005_bb0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12933-019-0820-6","article-title":"SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob\/ob\u2212\/\u2212 mice","volume":"18","author":"Adingupu","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.tips.2022.04.005_bb0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10557-017-6725-2","article-title":"SGLT-2 inhibition with dapagliflozin reduces the activation of the Nlrp3\/ASC inflammasome and attenuates the development of diabetic cardiomyopathy in mice with type 2 diabetes. further augmentation of the effects with saxagliptin, a DPP4 inhibitor","volume":"31","author":"Ye","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.tips.2022.04.005_bb0230","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1475-2840-12-172","article-title":"Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes","volume":"12","author":"Ram\u00edrez","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.tips.2022.04.005_bb0235","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1096\/fj.04-2263com","article-title":"Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart","volume":"18","author":"Sharma","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2022.04.005_bb0240","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/db10-0958","article-title":"Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling","volume":"60","author":"Denroche","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2022.04.005_bb0245","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1172\/JCI0213946","article-title":"Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression","volume":"109","author":"Belke","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2022.04.005_bb0250","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.108.792101","article-title":"Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart","volume":"119","author":"Boudina","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2022.04.005_bb0255","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yjmcc.2013.08.005","article-title":"Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms","volume":"64","author":"Fullmer","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0260","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI16885","article-title":"Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2\/PKB\u03b2","volume":"112","author":"Garofalo","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2022.04.005_bb0265","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1111\/jcmm.16687","article-title":"Cardiac metallothionein overexpression rescues diabetic cardiomyopathy in Akt2-knockout mice","volume":"25","author":"Huang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tips.2022.04.005_bb0270","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/CIRCULATIONAHA.114.012285","article-title":"Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor \u03b1","volume":"131","author":"Liu","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2022.04.005_bb0275","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/CIRCULATIONAHA.118.037216","article-title":"Glucose-sensitive myokine\/cardiokine MG53 regulates systemic insulin response and metabolic homeostasis","volume":"139","author":"Wu","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2022.04.005_bb0280","article-title":"The critical role of astragalus polysaccharides for the improvement of PPRA\u03b1-mediated lipotoxicity in diabetic cardiomyopathy","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2022.04.005_bb0285","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPAR\u03b1 overexpression mimics that caused by diabetes mellitus","volume":"109","author":"Finck","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2022.04.005_bb0290","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.2337\/diabetes.54.9.2514","article-title":"Cardiac-specific overexpression of PPARa causes insulin resistance in heart and liver","volume":"54","author":"Park","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2022.04.005_bb0295","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cardiores.2003.11.021","article-title":"Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart","volume":"61","author":"Desrois","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2022.04.005_bb0300","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.yjmcc.2004.05.014","article-title":"Gender differences in hypertrophy, insulin resistance and ischemic injury in the aging type 2 diabetic rat heart","volume":"37","author":"Desrois","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4684-5616-5_4","article-title":"Development of diabetes in the non-obese NIDDM rat (GK rat)","volume":"246","author":"Goto","year":"1988","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tips.2022.04.005_bb0310","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.tips.2022.04.005_bb0315","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.carpath.2013.06.002","article-title":"Obese and diabetic KKAy mice show increased mortality but improved cardiac function following myocardial infarction","volume":"22","author":"Heaberlin","year":"2013","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.tips.2022.04.005_bb0320","article-title":"Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts","volume":"6","author":"Mizuno","year":"2018","journal-title":"Phys. Rep."},{"key":"10.1016\/j.tips.2022.04.005_bb0325","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/dmrr.410","article-title":"Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-\u03b1 or -\u03b3 agonists in a type 2 diabetic animal model","volume":"19","author":"Kim","year":"2003","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.tips.2022.04.005_bb0330","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00335-017-9719-2","article-title":"Congenic mice demonstrate the presence of QTLs conferring obesity and hypercholesterolemia on chromosome 1 in the TALLYHO mouse","volume":"28","author":"Parkman","year":"2017","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.tips.2022.04.005_bb0335","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1677\/joe.1.06647","article-title":"Phenotypic characterization of polygenic type 2 diabetes in TALLYHO\/JngJ mice","volume":"191","author":"Kim","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tips.2022.04.005_bb0340","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1186\/1471-2164-11-713","article-title":"Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL\/6J \u00d7 TALLYHO\/JngJ) F2 mice","volume":"11","author":"Stewart","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tips.2022.04.005_bb0345","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/diab.40.11.1480","article-title":"Evolution of insulin resistance in New Zealand obese mice","volume":"40","author":"Veroni","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2022.04.005_bb0350","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fendo.2018.00732","article-title":"Sex differences in cardiac mitochondria in the New Zealand obese mouse","volume":"9","author":"John","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tips.2022.04.005_bb0355","doi-asserted-by":"crossref","first-page":"H1206","DOI":"10.1152\/ajpheart.00319.2008","article-title":"Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription","volume":"295","author":"Fang","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0360","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCRESAHA.108.189316","article-title":"Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure","volume":"104","author":"Symons","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2022.04.005_bb0365","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2337\/db12-0350","article-title":"Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction","volume":"62","author":"Hua","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2022.04.005_bb0370","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/cvr\/cvp017","article-title":"Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding","volume":"82","author":"Wright","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2022.04.005_bb0375","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jnutbio.2018.09.007","article-title":"Long-term exposure to high-sucrose diet down-regulates hepatic endoplasmic reticulum-stress adaptive pathways and potentiates de novo lipogenesis in weaned male mice","volume":"62","author":"Flister","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.tips.2022.04.005_bb0380","doi-asserted-by":"crossref","first-page":"C772","DOI":"10.1152\/ajpcell.00086.2005","article-title":"Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance","volume":"291","author":"Vasanji","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0385","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molmet.2015.04.001","article-title":"Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy","volume":"4","author":"Katunga","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tips.2022.04.005_bb0390","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jnutbio.2019.03.022","article-title":"Cardiac remodeling and higher sensitivity to ischemia\u2013reperfusion injury in female rats submitted to high-fat high-sucrose diet: an in vivo\/ex vivo longitudinal follow-up","volume":"69","author":"Fourny","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.tips.2022.04.005_bb0395","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1096\/fj.201900767R","article-title":"The nuclear and mitochondrial sirtuins, Sirt6 and Sirt3, regulate each other\u2019s activity and protect the heart from developing obesity-mediated diabetic cardiomyopathy","volume":"33","author":"Kanwal","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2022.04.005_bb0400","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1096\/fj.13-239822","article-title":"Akt-mediated cardioprotective effects of aldosterone in type 2 diabetic mice","volume":"28","author":"Fazal","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2022.04.005_bb0405","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.yjmcc.2011.03.002","article-title":"Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice","volume":"50","author":"Mellor","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0410","doi-asserted-by":"crossref","first-page":"H964","DOI":"10.1152\/ajpheart.00797.2011","article-title":"Fructose diet treatment in mice induces fundamental disturbance of cardiomyocyte Ca 2+ handling and myofilament responsiveness","volume":"302","author":"Mellor","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0415","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/db15-1274","article-title":"Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy","volume":"66","author":"Gu","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2022.04.005_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154002","article-title":"Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function","volume":"102","author":"Sun","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.tips.2022.04.005_bb0425","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3389\/fphys.2019.01395","article-title":"Characterising an alternative murine model of diabetic cardiomyopathy","volume":"10","author":"Tate","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0430","doi-asserted-by":"crossref","first-page":"H840","DOI":"10.1152\/ajpheart.00632.2019","article-title":"Gene therapy targeting cardiac phosphoinositide 3-kinase (p110\u03b1) attenuates cardiac remodeling in type 2 diabetes","volume":"318","author":"Prakoso","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0435","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/dc21-S002","article-title":"Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u20142021","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tips.2022.04.005_bb0440","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1042\/CS20170063","article-title":"(2017) Phosphoinositide 3-kinase (p110\u03b1) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction","volume":"131","author":"Prakoso","year":"1979","journal-title":"Clin. Sci."},{"key":"10.1016\/j.tips.2022.04.005_bb0445","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lfs.2019.02.017","article-title":"Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy","volume":"221","author":"Althunibat","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.tips.2022.04.005_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6905720","article-title":"Spironolactone protects against diabetic cardiomyopathy in streptozotocin-induced diabetic rats","volume":"2018","author":"Liu","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.tips.2022.04.005_bb0455","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2613.2008.00579.x","article-title":"Dysregulation of matrix metalloproteinases and their tissue inhibitors is related to abnormality of left ventricular geometry and function in streptozotocin-induced diabetic minipigs","volume":"89","author":"Lu","year":"2008","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.tips.2022.04.005_bb0460","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.4161\/cc.27997","article-title":"Successful \u03b2 cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2\/CDK4\/GLP1","volume":"13","author":"Chen","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tips.2022.04.005_bb0465","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.taap.2011.11.009","article-title":"Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis","volume":"258","author":"Das","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tips.2022.04.005_bb0470","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12933-018-0803-z","article-title":"Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits","volume":"17","author":"Zhang","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.tips.2022.04.005_bb0475","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008807","article-title":"Xanthine oxidase inhibitor allopurinol prevents oxidative stress-mediated atrial remodeling in alloxan-induced diabetes mellitus rabbits","volume":"7","author":"Yang","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.tips.2022.04.005_bb0480","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1475-2840-9-43","article-title":"Oxidant-NO dependent gene regulation in dogs with type I diabetes: impact on cardiac function and metabolism","volume":"9","author":"Ojaimi","year":"2010","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.tips.2022.04.005_bb0485","doi-asserted-by":"crossref","first-page":"H2587","DOI":"10.1152\/ajpheart.00516.2003","article-title":"Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart","volume":"285","author":"Liu","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0490","doi-asserted-by":"crossref","first-page":"I31","DOI":"10.1161\/CIRCULATIONAHA.106.680157","article-title":"Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes","volume":"116","author":"Boodhwani","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2022.04.005_bb0495","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1152\/japplphysiol.00235.2006","article-title":"Exercise training prevents Ca 2+ dysregulation in coronary smooth muscle from diabetic dyslipidemic Yucatan swine","volume":"101","author":"Witczak","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0500","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00395-011-0156-1","article-title":"A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart","volume":"106","author":"Cole","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.tips.2022.04.005_bb0505","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12012-016-9370-2","article-title":"Anti-apoptotic and pro-survival effects of food restriction on high-fat diet-induced obese hearts","volume":"17","author":"Lin","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.tips.2022.04.005_bb0510","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1475-2840-12-44","article-title":"Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker","volume":"12","author":"Nunes","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.tips.2022.04.005_bb0515","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10557-018-6780-3","article-title":"Pterostilbene decreases cardiac oxidative stress and inflammation via activation of AMPK\/Nrf2\/HO-1 pathway in fructose-fed diabetic rats","volume":"32","author":"Kosuru","year":"2018","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.tips.2022.04.005_bb0520","article-title":"Alterations in fatty acid metabolism and sirtuin signaling characterize early type-2 diabetic hearts of fructose-fed rats","volume":"5","author":"Lou","year":"2017","journal-title":"Phys. Rep."},{"key":"10.1016\/j.tips.2022.04.005_bb0525","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/aps.2017.50","article-title":"Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1\u03b1 deacetylation","volume":"39","author":"Fang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.tips.2022.04.005_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110081","article-title":"Protective effects of AS-IV on diabetic cardiomyopathy by improving myocardial lipid metabolism in rat models of T2DM","volume":"127","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tips.2022.04.005_bb0535","first-page":"1638","article-title":"(2006) Sex difference in cardiomyocyte function in normal and metallothionein transgenic mice: the effect of diabetes mellitus","volume":"100","author":"Ceylan-Isik","year":"1985","journal-title":"J. Appl. Physiol. Bethesda Md"},{"key":"10.1016\/j.tips.2022.04.005_bb0540","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1038\/s41598-018-20703-8","article-title":"Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia","volume":"8","author":"Chandramouli","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614722000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614722000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:14:40Z","timestamp":1759050880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614722000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":108,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0165614722000852"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2022.04.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current landscape of preclinical models of diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2022.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}